{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:17:54Z","timestamp":1787163474034,"version":"build-2736575974"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:00:00Z","timestamp":1768003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"vor","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"JST SPRING","award":["JPMJSP2142"],"award-info":[{"award-number":["JPMJSP2142"]}]},{"name":"a Grant-in-Aid for Scientific Research on Innovative Areas JSPS KAKENHI","award":["JP19H05767A02"],"award-info":[{"award-number":["JP19H05767A02"]}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K06744"],"award-info":[{"award-number":["22K06744"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004330","name":"Smoking Research Foundation","doi-asserted-by":"publisher","award":["2021G021"],"award-info":[{"award-number":["2021G021"]}],"id":[{"id":"10.13039\/501100004330","id-type":"DOI","asserted-by":"publisher"}]},{"name":"a grant from the Takeda Science Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-35368-x","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T15:06:14Z","timestamp":1768057574000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Disruption of intracellular iron homeostasis through mitochondrial dysfunction associated with suppression of ATP 13A2 expression"],"prefix":"10.1038","volume":"16","author":[{"given":"Takanori","family":"Murakami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Ohuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Kiuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisaka","family":"Kurita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanta","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Kakiuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasuku","family":"Hirayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideko","family":"Nagasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiliang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi","family":"Maekawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"Hozumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Inden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,10]]},"reference":[{"key":"35368_CR1","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/s0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak, H. et al. Staging of brain pathology related to sporadic parkinson\u2019s disease. Neurobiol. Aging. 24, 197\u2013211. https:\/\/doi.org\/10.1016\/s0197-4580(02)00065-9 (2003).","journal-title":"Neurobiol. Aging"},{"key":"35368_CR2","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/nrd.2018.136","volume":"17","author":"D Charvin","year":"2018","unstructured":"Charvin, D., Medori, R., Hauser, R. A. & Rascol, O. Therapeutic strategies for Parkinson disease: beyond dopaminergic drugs. Nat. Rev. Drug Discov. 17, 804\u2013822. https:\/\/doi.org\/10.1038\/nrd.2018.136 (2018).","journal-title":"Nat. Rev. Drug Discov"},{"key":"35368_CR3","doi-asserted-by":"publisher","first-page":"102077","DOI":"10.1016\/j.arr.2023.102077","volume":"91","author":"XS Ding","year":"2023","unstructured":"Ding, X. S. et al. Ferroptosis in parkinson\u2019s disease: molecular mechanisms and therapeutic potential. Ageing Res. Rev. 91, 102077. https:\/\/doi.org\/10.1016\/j.arr.2023.102077 (2023).","journal-title":"Ageing Res. Rev."},{"key":"35368_CR4","doi-asserted-by":"publisher","first-page":"105920","DOI":"10.1016\/j.nbd.2022.105920","volume":"175","author":"RM Wise","year":"2022","unstructured":"Wise, R. M. et al. Interactions of dopamine, iron, and alpha-synuclein linked to dopaminergic neuron vulnerability in parkinson\u2019s disease and neurodegeneration with brain iron accumulation disorders. Neurobiol. Dis. 175, 105920. https:\/\/doi.org\/10.1016\/j.nbd.2022.105920 (2022).","journal-title":"Neurobiol. Dis."},{"key":"35368_CR5","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3389\/fnagi.2018.00109","volume":"10","author":"XS Zeng","year":"2018","unstructured":"Zeng, X. S., Geng, W. S., Jia, J. J., Chen, L. & Zhang, P. P. Cellular and molecular basis of neurodegeneration in Parkinson disease. Front. Aging Neurosci. 10, 109. https:\/\/doi.org\/10.3389\/fnagi.2018.00109 (2018).","journal-title":"Front. Aging Neurosci."},{"key":"35368_CR6","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/ana.26467","volume":"92","author":"MT Perinan","year":"2022","unstructured":"Perinan, M. T. et al. Effect modification between genes and environment and parkinson\u2019s disease risk. Ann. Neurol. 92, 715\u2013724. https:\/\/doi.org\/10.1002\/ana.26467 (2022).","journal-title":"Ann. Neurol."},{"key":"35368_CR7","doi-asserted-by":"publisher","first-page":"104782","DOI":"10.1016\/j.nbd.2020.104782","volume":"137","author":"S Bandres-Ciga","year":"2020","unstructured":"Bandres-Ciga, S., Diez-Fairen, M., Kim, J. J. & Singleton, A. B. Genetics of parkinson\u2019s disease: an introspection of its journey towards precision medicine. Neurobiol. Dis. 137, 104782. https:\/\/doi.org\/10.1016\/j.nbd.2020.104782 (2020).","journal-title":"Neurobiol. Dis."},{"key":"35368_CR8","doi-asserted-by":"publisher","unstructured":"Gialluisi, A. et al. Identification of sixteen novel candidate genes for late onset Parkinson\u2019s disease. Mol. Neurodegener. 16 https:\/\/doi.org\/10.1186\/s13024-021-00455-2 (2021).","DOI":"10.1186\/s13024-021-00455-2"},{"key":"35368_CR9","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1038\/s41467-021-23452-x","volume":"12","author":"H Matsui","year":"2021","unstructured":"Matsui, H. et al. Cytosolic DsDNA of mitochondrial origin induces cytotoxicity and neurodegeneration in cellular and zebrafish models of parkinson\u2019s disease. Nat. Commun. 12, 3101. https:\/\/doi.org\/10.1038\/s41467-021-23452-x (2021).","journal-title":"Nat. Commun."},{"key":"35368_CR10","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1002\/mds.29190","volume":"37","author":"Y Meng","year":"2022","unstructured":"Meng, Y. et al. Putaminal Recombinant glucocerebrosidase delivery with magnetic Resonance-Guided focused ultrasound in parkinson\u2019s disease: A phase I study. Mov. Disord. 37, 2134\u20132139. https:\/\/doi.org\/10.1002\/mds.29190 (2022).","journal-title":"Mov. Disord"},{"key":"35368_CR11","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13024-023-00676-7","volume":"18","author":"MT Henrich","year":"2023","unstructured":"Henrich, M. T., Oertel, W. H., Surmeier, D. J. & Geibl, F. F. Mitochondrial dysfunction in parkinson\u2019s disease - a key disease hallmark with therapeutic potential. Mol. Neurodegener. 18, 83. https:\/\/doi.org\/10.1186\/s13024-023-00676-7 (2023).","journal-title":"Mol. Neurodegener"},{"key":"35368_CR12","doi-asserted-by":"publisher","first-page":"100209","DOI":"10.1074\/jbc.REV120.014294","volume":"296","author":"EH Clark","year":"2021","unstructured":"Clark, E. H., de la Torre, V., Hoshikawa, A., Briston, T. & T. & Targeting mitophagy in parkinson\u2019s disease. J. Biol. Chem. 296, 100209. https:\/\/doi.org\/10.1074\/jbc.REV120.014294 (2021).","journal-title":"J. Biol. Chem."},{"key":"35368_CR13","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/gm566","volume":"6","author":"MK Lin","year":"2014","unstructured":"Lin, M. K. & Farrer, M. J. Genetics and genomics of parkinson\u2019s disease. Genome Med. 6, 48. https:\/\/doi.org\/10.1186\/gm566 (2014).","journal-title":"Genome Med."},{"key":"35368_CR14","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1080\/15548627.2018.1509818","volume":"15","author":"H Li","year":"2019","unstructured":"Li, H. et al. Mitochondrial dysfunction and mitophagy defect triggered by heterozygous GBA mutations. Autophagy 15, 113\u2013130. https:\/\/doi.org\/10.1080\/15548627.2018.1509818 (2019).","journal-title":"Autophagy"},{"key":"35368_CR15","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem, B. R., Okun, M. S. & Klein, C. Parkinson\u2019s disease. Lancet 397, 2284\u20132303. https:\/\/doi.org\/10.1016\/S0140-6736(21)00218-X (2021).","journal-title":"Lancet"},{"key":"35368_CR16","doi-asserted-by":"publisher","unstructured":"Tian, Y. et al. Iron metabolism in aging and Age-Related diseases. Int. J. Mol. Sci. 23 https:\/\/doi.org\/10.3390\/ijms23073612 (2022).","DOI":"10.3390\/ijms23073612"},{"key":"35368_CR17","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1038\/ng1884","volume":"38","author":"A Ramirez","year":"2006","unstructured":"Ramirez, A. et al. Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat. Genet. 38, 1184\u20131191. https:\/\/doi.org\/10.1038\/ng1884 (2006).","journal-title":"Nat. Genet."},{"key":"35368_CR18","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1002\/mds.22947","volume":"25","author":"SA Schneider","year":"2010","unstructured":"Schneider, S. A. et al. ATP13A2 mutations (PARK9) cause neurodegeneration with brain iron accumulation. Mov. Disord. 25, 979\u2013984. https:\/\/doi.org\/10.1002\/mds.22947 (2010).","journal-title":"Mov. Disord"},{"key":"35368_CR19","doi-asserted-by":"publisher","first-page":"9611","DOI":"10.1073\/pnas.1112368109","volume":"109","author":"B Dehay","year":"2012","unstructured":"Dehay, B. et al. Loss of P-type ATPase ATP13A2\/PARK9 function induces general lysosomal deficiency and leads to Parkinson disease neurodegeneration. Proc. Natl. Acad. Sci. U S A. 109, 9611\u20139616. https:\/\/doi.org\/10.1073\/pnas.1112368109 (2012).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"35368_CR20","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/s41586-020-1968-7","volume":"578","author":"S van Veen","year":"2020","unstructured":"van Veen, S. et al. ATP13A2 deficiency disrupts lysosomal polyamine export. Nature 578, 419\u2013424. https:\/\/doi.org\/10.1038\/s41586-020-1968-7 (2020).","journal-title":"Nature"},{"key":"35368_CR21","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1038\/s41467-023-37815-z","volume":"14","author":"T Fujii","year":"2023","unstructured":"Fujii, T. et al. Parkinson\u2019s disease-associated ATP13A2\/PARK9 functions as a lysosomal H(+),K(+)-ATPase. Nat. Commun. 14, 2174. https:\/\/doi.org\/10.1038\/s41467-023-37815-z (2023).","journal-title":"Nat. Commun."},{"key":"35368_CR22","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1016\/j.bbamem.2015.04.008","volume":"1848","author":"DE Rinaldi","year":"2015","unstructured":"Rinaldi, D. E., Corradi, G. R., Cuesta, L. M. & Adamo, H. P. Tezanos Pinto, F. The Parkinson-associated human P5B-ATPase ATP13A2 protects against the iron-induced cytotoxicity. Biochim. Biophys. Acta. 1848, 1646\u20131655. https:\/\/doi.org\/10.1016\/j.bbamem.2015.04.008 (2015). de.","journal-title":"Biochim. Biophys. Acta"},{"key":"35368_CR23","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.tibs.2015.02.003","volume":"40","author":"BJ Ryan","year":"2015","unstructured":"Ryan, B. J., Hoek, S., Fon, E. A. & Wade-Martins, R. Mitochondrial dysfunction and mitophagy in parkinson\u2019s: from Familial to sporadic disease. Trends Biochem. Sci. 40, 200\u2013210. https:\/\/doi.org\/10.1016\/j.tibs.2015.02.003 (2015).","journal-title":"Trends Biochem. Sci."},{"key":"35368_CR24","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.stem.2016.08.002","volume":"19","author":"CH Hsieh","year":"2016","unstructured":"Hsieh, C. H. et al. Functional impairment in Miro degradation and mitophagy is a shared feature in Familial and sporadic parkinson\u2019s disease. Cell. Stem Cell. 19, 709\u2013724. https:\/\/doi.org\/10.1016\/j.stem.2016.08.002 (2016).","journal-title":"Cell. Stem Cell."},{"key":"35368_CR25","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1021\/cr020628n","volume":"104","author":"M Costas","year":"2004","unstructured":"Costas, M., Mehn, M. P., Jensen, M. P. & Que, L. Jr. Dioxygen activation at mononuclear nonheme iron active sites: enzymes, models, and intermediates. Chem. Rev. 104, 939\u2013986. https:\/\/doi.org\/10.1021\/cr020628n (2004).","journal-title":"Chem. Rev."},{"key":"35368_CR26","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1073\/pnas.1314885111","volume":"111","author":"S Enami","year":"2014","unstructured":"Enami, S., Sakamoto, Y. & Colussi, A. J. Fenton chemistry at aqueous interfaces. Proc. Natl. Acad. Sci. U S A. 111, 623\u2013628. https:\/\/doi.org\/10.1073\/pnas.1314885111 (2014).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"35368_CR27","doi-asserted-by":"publisher","unstructured":"Lee, J. & Hyun, D. H. The interplay between intracellular iron homeostasis and neuroinflammation in neurodegenerative diseases. Antioxid. (Basel). 12 https:\/\/doi.org\/10.3390\/antiox12040918 (2023).","DOI":"10.3390\/antiox12040918"},{"key":"35368_CR28","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1038\/nrn1537","volume":"5","author":"L Zecca","year":"2004","unstructured":"Zecca, L., Youdim, M. B., Riederer, P., Connor, J. R. & Crichton, R. R. Iron, brain ageing and neurodegenerative disorders. Nat. Rev. Neurosci. 5, 863\u2013873. https:\/\/doi.org\/10.1038\/nrn1537 (2004).","journal-title":"Nat. Rev. Neurosci."},{"key":"35368_CR29","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.molcel.2005.05.027","volume":"19","author":"H Ishikawa","year":"2005","unstructured":"Ishikawa, H. et al. Involvement of Heme regulatory motif in Heme-mediated ubiquitination and degradation of IRP2. Mol. Cell. 19, 171\u2013181. https:\/\/doi.org\/10.1016\/j.molcel.2005.05.027 (2005).","journal-title":"Mol. Cell."},{"key":"35368_CR30","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.1021\/acssensors.0c01445","volume":"5","author":"T Hirayama","year":"2020","unstructured":"Hirayama, T., Niwa, M., Hirosawa, S. & Nagasawa, H. High-Throughput screening for the discovery of iron homeostasis modulators using an extremely sensitive fluorescent probe. ACS Sens. 5, 2950\u20132958. https:\/\/doi.org\/10.1021\/acssensors.0c01445 (2020).","journal-title":"ACS Sens."},{"key":"35368_CR31","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1039\/c8mt00049b","volume":"10","author":"T Hirayama","year":"2018","unstructured":"Hirayama, T., Kadota, S., Niwa, M. & Nagasawa, H. A mitochondria-targeted fluorescent probe for selective detection of mitochondrial labile Fe(ii). Metallomics 10, 794\u2013801. https:\/\/doi.org\/10.1039\/c8mt00049b (2018).","journal-title":"Metallomics"},{"key":"35368_CR32","doi-asserted-by":"publisher","first-page":"6590","DOI":"10.1039\/c4ob00935e","volume":"12","author":"M Niwa","year":"2014","unstructured":"Niwa, M., Hirayama, T., Okuda, K. & Nagasawa, H. A new class of high-contrast Fe(II) selective fluorescent probes based on spirocyclized scaffolds for visualization of intracellular labile iron delivered by transferrin. Org. Biomol. Chem. 12, 6590\u20136597. https:\/\/doi.org\/10.1039\/c4ob00935e (2014).","journal-title":"Org. Biomol. Chem."},{"key":"35368_CR33","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1039\/c8sc04386h","volume":"10","author":"T Hirayama","year":"2019","unstructured":"Hirayama, T. et al. A Golgi-targeting fluorescent probe for labile Fe(ii) to reveal an abnormal cellular iron distribution induced by dysfunction of VPS35. Chem. Sci. 10, 1514\u20131521. https:\/\/doi.org\/10.1039\/c8sc04386h (2019).","journal-title":"Chem. Sci."},{"key":"35368_CR34","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.1021\/jacs.1c08485","volume":"144","author":"K Kawai","year":"2022","unstructured":"Kawai, K. et al. Molecular imaging of labile Heme in living cells using a small molecule fluorescent probe. J. Am. Chem. Soc. 144, 3793\u20133803. https:\/\/doi.org\/10.1021\/jacs.1c08485 (2022).","journal-title":"J. Am. Chem. Soc."},{"key":"35368_CR35","doi-asserted-by":"publisher","first-page":"4918","DOI":"10.1038\/s41467-022-32625-1","volume":"13","author":"YX Xie","year":"2022","unstructured":"Xie, Y. X. et al. Lysosomal exocytosis releases pathogenic alpha-synuclein species from neurons in synucleinopathy models. Nat. Commun. 13, 4918. https:\/\/doi.org\/10.1038\/s41467-022-32625-1 (2022).","journal-title":"Nat. Commun."},{"key":"35368_CR36","doi-asserted-by":"publisher","first-page":"238","DOI":"10.2174\/1570159x13666151030103027","volume":"14","author":"P Rivero-Rios","year":"2016","unstructured":"Rivero-Rios, P., Madero-Perez, J., Fernandez, B. & Hilfiker, S. Targeting the Autophagy\/Lysosomal degradation pathway in parkinson\u2019s disease. Curr. Neuropharmacol. 14, 238\u2013249. https:\/\/doi.org\/10.2174\/1570159x13666151030103027 (2016).","journal-title":"Curr. Neuropharmacol."},{"key":"35368_CR37","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1186\/1471-2164-15-1154","volume":"15","author":"A Krishna","year":"2014","unstructured":"Krishna, A. et al. Systems genomics evaluation of the SH-SY5Y neuroblastoma cell line as a model for parkinson\u2019s disease. BMC Genom. 15, 1154. https:\/\/doi.org\/10.1186\/1471-2164-15-1154 (2014).","journal-title":"BMC Genom."},{"key":"35368_CR38","doi-asserted-by":"publisher","first-page":"4240","DOI":"10.1523\/JNEUROSCI.5575-11.2012","volume":"32","author":"M Usenovic","year":"2012","unstructured":"Usenovic, M., Tresse, E., Mazzulli, J. R., Taylor, J. P. & Krainc, D. Deficiency of ATP13A2 leads to lysosomal dysfunction, alpha-synuclein accumulation, and neurotoxicity. J. Neurosci. 32, 4240\u20134246. https:\/\/doi.org\/10.1523\/JNEUROSCI.5575-11.2012 (2012).","journal-title":"J. Neurosci."},{"key":"35368_CR39","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41531-024-00748-5","volume":"10","author":"ML Erb","year":"2024","unstructured":"Erb, M. L., Sipple, K., Levine, N., Chen, X. & Moore, D. J. Adult-onset deletion of ATP13A2 in mice induces progressive nigrostriatal pathway dopaminergic degeneration and lysosomal abnormalities. NPJ Parkinsons Dis. 10, 133. https:\/\/doi.org\/10.1038\/s41531-024-00748-5 (2024).","journal-title":"NPJ Parkinsons Dis."},{"key":"35368_CR40","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1083\/jcb.201804165","volume":"218","author":"R Wang","year":"2019","unstructured":"Wang, R. et al. ATP13A2 facilitates HDAC6 recruitment to lysosome to promote autophagosome-lysosome fusion. J. Cell. Biol. 218, 267\u2013284. https:\/\/doi.org\/10.1083\/jcb.201804165 (2019).","journal-title":"J. Cell. Biol."},{"key":"35368_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2741\/s498","volume":"10","author":"A Kolnagou","year":"2018","unstructured":"Kolnagou, A., Kontoghiorghe, C. N. & Kontoghiorghes, G. J. New targeted therapies and diagnostic methods for iron overload diseases. Front. Biosci. (Schol Ed). 10, 1\u201320. https:\/\/doi.org\/10.2741\/s498 (2018).","journal-title":"Front. Biosci. (Schol Ed)"},{"key":"35368_CR42","doi-asserted-by":"publisher","unstructured":"Terzi, E. M., Sviderskiy, V. O., Alvarez, S. W., Whiten, G. C. & Possemato, R. Iron-sulfur cluster deficiency can be sensed by IRP2 and regulates iron homeostasis and sensitivity to ferroptosis independent of IRP1 and FBXL5. Sci. Adv. 7 https:\/\/doi.org\/10.1126\/sciadv.abg4302 (2021).","DOI":"10.1126\/sciadv.abg4302"},{"key":"35368_CR43","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1146\/annurev.nutr.28.061807.155521","volume":"28","author":"MU Muckenthaler","year":"2008","unstructured":"Muckenthaler, M. U., Galy, B. & Hentze, M. W. Systemic iron homeostasis and the iron-responsive element\/iron-regulatory protein (IRE\/IRP) regulatory network. Annu. Rev. Nutr. 28, 197\u2013213. https:\/\/doi.org\/10.1146\/annurev.nutr.28.061807.155521 (2008).","journal-title":"Annu. Rev. Nutr."},{"key":"35368_CR44","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1073\/pnas.80.8.2263","volume":"80","author":"RD Klausner","year":"1983","unstructured":"Klausner, R. D., Ashwell, G., van Renswoude, J., Harford, J. B. & Bridges, K. R. Binding of apotransferrin to K562 cells: explanation of the transferrin cycle. Proc. Natl. Acad. Sci. U S A. 80, 2263\u20132266. https:\/\/doi.org\/10.1073\/pnas.80.8.2263 (1983).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"35368_CR45","doi-asserted-by":"publisher","first-page":"33674","DOI":"10.1038\/srep33674","volume":"6","author":"X Du","year":"2016","unstructured":"Du, X. et al. Activation of ATP-sensitive potassium channels enhances DMT1-mediated iron uptake in SK-N-SH cells in vitro. Sci. Rep. 6, 33674. https:\/\/doi.org\/10.1038\/srep33674 (2016).","journal-title":"Sci. Rep."},{"key":"35368_CR46","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.mcn.2018.08.006","volume":"92","author":"Q Zhang","year":"2018","unstructured":"Zhang, Q. et al. Deletion of Kir6.2\/SUR1 potassium channels rescues diminishing of DA neurons via decreasing iron accumulation in PD. Mol. Cell. Neurosci. 92, 164\u2013176. https:\/\/doi.org\/10.1016\/j.mcn.2018.08.006 (2018).","journal-title":"Mol. Cell. Neurosci."},{"key":"35368_CR47","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13024-016-0121-4","volume":"11","author":"J Kim","year":"2016","unstructured":"Kim, J. et al. miR-27a and miR-27b regulate autophagic clearance of damaged mitochondria by targeting PTEN-induced putative kinase 1 (PINK1). Mol. Neurodegener. 11, 55. https:\/\/doi.org\/10.1186\/s13024-016-0121-4 (2016).","journal-title":"Mol. Neurodegener"},{"key":"35368_CR48","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1523\/JNEUROSCI.3117-15.2016","volume":"36","author":"S Rajagopalan","year":"2016","unstructured":"Rajagopalan, S., Rane, A., Chinta, S. J. & Andersen, J. K. Regulation of ATP13A2 via PHD2-HIF1alpha signaling is critical for cellular iron homeostasis: implications for parkinson\u2019s disease. J. Neurosci. 36, 1086\u20131095. https:\/\/doi.org\/10.1523\/JNEUROSCI.3117-15.2016 (2016).","journal-title":"J. Neurosci."},{"key":"35368_CR49","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1007\/s00702-012-0905-9","volume":"119","author":"H Mochizuki","year":"2012","unstructured":"Mochizuki, H. & Yasuda, T. Iron accumulation in parkinson\u2019s disease. J. Neural Transm (Vienna). 119, 1511\u20131514. https:\/\/doi.org\/10.1007\/s00702-012-0905-9 (2012).","journal-title":"J. Neural Transm (Vienna)"},{"key":"35368_CR50","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s00415-002-0704-6","volume":"249","author":"C Borie","year":"2002","unstructured":"Borie, C. et al. Association study between iron-related genes polymorphisms and parkinson\u2019s disease. J. Neurol. 249, 801\u2013804. https:\/\/doi.org\/10.1007\/s00415-002-0704-6 (2002).","journal-title":"J. Neurol."},{"key":"35368_CR51","doi-asserted-by":"publisher","first-page":"18578","DOI":"10.1073\/pnas.0804373105","volume":"105","author":"J Salazar","year":"2008","unstructured":"Salazar, J. et al. Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of parkinson\u2019s disease. Proc. Natl. Acad. Sci. U S A. 105, 18578\u201318583. https:\/\/doi.org\/10.1073\/pnas.0804373105 (2008).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"35368_CR52","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1056\/NEJMoa2209254","volume":"387","author":"D Devos","year":"2022","unstructured":"Devos, D. et al. Trial of deferiprone in parkinson\u2019s disease. N Engl. J. Med. 387, 2045\u20132055. https:\/\/doi.org\/10.1056\/NEJMoa2209254 (2022).","journal-title":"N Engl. J. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35368-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35368-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35368-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T10:28:50Z","timestamp":1770287330000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-35368-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,10]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["35368"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-35368-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,10]]},"assertion":[{"value":"12 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5007"}}